Literature DB >> 12643747

Quantitative analysis of permeation peptide complexes labeled with Technetium-99m: chiral and sequence-specific effects on net cell uptake.

Seth T Gammon1, Victor M Villalobos, Julie L Prior, Vijay Sharma, David Piwnica-Worms.   

Abstract

This study investigated sequence-specific cell uptake characteristics of Tat basic domain and related permeation peptides with an emphasis on residue chirality, length, and modified side chains. Effects on cell permeation of defined basic domain sequences within a library of 42 different peptides were evaluated using transport of radiolabeled peptides into human Jurkat leukemia cells. All other factors being equal, when the chirality of the peptide sequence was changed from l to d, uptake values increased up to 13-fold. Control experiments showed that the quantitative difference in uptake could not be attributed to increased decomposition of an l- versus a d-peptide by cellular or serum proteases. Furthermore, length, sequence, and type of chelation domain impacted peptide uptake into cells. The highest level of uptake was found with the following peptides: (23) d-Tat-Orn [Ac-rkkrr-orn-rrr-AHA-kgc-amide] and (33) d-poly-Arg(9) [Ac-rrrrrrrrr-AHA-kgc-amide]. The best of these peptide sequences could be employed as in vivo imaging and drug delivery agents to translocate substrates into cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12643747     DOI: 10.1021/bc0256291

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  19 in total

1.  Peptide-mediated activation of Akt and extracellular regulated kinase signaling prevents lymphocyte apoptosis.

Authors:  Jonathan E McDunn; Jared T Muenzer; Latif Rachdi; Katherine C Chang; Chris G Davis; W Michael Dunne; David Piwnica-Worms; Ernesto Bernal-Mizrachi; Richard S Hotchkiss
Journal:  FASEB J       Date:  2007-09-13       Impact factor: 5.191

2.  Development of novel peptides for mitochondrial drug delivery: amino acids featuring delocalized lipophilic cations.

Authors:  Shana O Kelley; Kelly M Stewart; Rida Mourtada
Journal:  Pharm Res       Date:  2011-08-11       Impact factor: 4.200

3.  Temperature-, concentration- and cholesterol-dependent translocation of L- and D-octa-arginine across the plasma and nuclear membrane of CD34+ leukaemia cells.

Authors:  Marjan M Fretz; Neal A Penning; Saly Al-Taei; Shiroh Futaki; Toshihide Takeuchi; Ikuhiko Nakase; Gert Storm; Arwyn T Jones
Journal:  Biochem J       Date:  2007-04-15       Impact factor: 3.857

4.  Bim-Bcl-2 homology 3 mimetic therapy is effective at suppressing inflammatory arthritis through the activation of myeloid cell apoptosis.

Authors:  John C Scatizzi; Jack Hutcheson; Richard M Pope; Gary S Firestein; Alisa E Koch; Melissa Mavers; Avraham Smason; Hemant Agrawal; G Kenneth Haines; Navdeep S Chandel; Richard S Hotchkiss; Harris Perlman
Journal:  Arthritis Rheum       Date:  2010-02

5.  Understanding Cell Penetration of Cyclic Peptides.

Authors:  Patrick G Dougherty; Ashweta Sahni; Dehua Pei
Journal:  Chem Rev       Date:  2019-05-14       Impact factor: 60.622

6.  Tumor imaging by means of proteolytic activation of cell-penetrating peptides.

Authors:  Tao Jiang; Emilia S Olson; Quyen T Nguyen; Melinda Roy; Patricia A Jennings; Roger Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-15       Impact factor: 11.205

7.  The CDK domain of p21 is a suppressor of IL-1beta-mediated inflammation in activated macrophages.

Authors:  John C Scatizzi; Melissa Mavers; Jack Hutcheson; Brittany Young; Bo Shi; Richard M Pope; Eric M Ruderman; Damien S K Samways; John A Corbett; Terrance M Egan; Harris Perlman
Journal:  Eur J Immunol       Date:  2009-03       Impact factor: 5.532

8.  Targeting AKT with the proapoptotic peptide, TAT-CTMP: a novel strategy for the treatment of human pancreatic adenocarcinoma.

Authors:  Peter O Simon; Jonathan E McDunn; Hiroyuki Kashiwagi; Katherine Chang; Peter S Goedegebuure; Richard S Hotchkiss; William G Hawkins
Journal:  Int J Cancer       Date:  2009-08-15       Impact factor: 7.396

9.  Binding and clustering of glycosaminoglycans: a common property of mono- and multivalent cell-penetrating compounds.

Authors:  André Ziegler; Joachim Seelig
Journal:  Biophys J       Date:  2007-12-07       Impact factor: 4.033

Review 10.  Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems.

Authors:  S D Laufer; T Restle
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.